Compare WKHS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKHS | SCNX |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 24.8M |
| IPO Year | N/A | 2020 |
| Metric | WKHS | SCNX |
|---|---|---|
| Price | $5.37 | $0.58 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | 380.5K | ★ 1.7M |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,620,296.00 | $653,391.00 |
| Revenue This Year | $92.70 | N/A |
| Revenue Next Year | $34.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.73 | ★ 207.88 |
| 52 Week Low | $5.10 | $0.46 |
| 52 Week High | $139.70 | $8.00 |
| Indicator | WKHS | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 65.44 | 46.83 |
| Support Level | $5.10 | $0.49 |
| Resistance Level | $6.00 | $0.60 |
| Average True Range (ATR) | 0.87 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 41.72 | 31.89 |
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.